Dave Robinson

Dave has been an active member of the cardiac electrophysiology community for over 30 years. In 1991, as an employee of Quinton Electrophysiology Systems, he had the opportunity to meet many emerging leaders in the field. In1996, Dave joined Cardiac Pathways’ product development team, where he supported enrollment of a randomized controlled trial evaluating the safety and efficacy of an irrigated catheter system for ablating ventricular tachycardia. In 2001, after the acquisition by Boston Scientific, Dave supported its domestic and international initiatives. Next, at Voyage Medical (2006), in the capacity of VP of Clinical Marketing, he assisted in the development of a cardiac ablation direct visualization system. In 2012, Dave became an independent consultant, introducing emerging technologies to clinicians in the United States and OUS markets. He joined the inHeart Medical team in 2015.